Flagler Health Raises $50 Million in Series B Funding
Flagler Health, a company specializing in AI-native operating systems for musculoskeletal (MSK) care, has successfully raised $50 million in a Series B funding round. The round was led by Bessemer Venture Partners, with participation from a consortium of investors including SignalFire, Alumni Ventures, Streamlined, 186 Ventures, Proof VC, Tribeca Ventures, and Offscript.
Flagler Health, based in New York City, develops software that integrates seamlessly into existing electronic medical records (EMRs) to coordinate clinical and administrative workflows throughout the entire patient lifecycle. This technology aims to streamline MSK care, making it more efficient and effective for healthcare providers.
Leadership and Vision
The company was co-founded by Albert Katz, who serves as CEO, along with Leon Anijar, the Chief Medical Officer, and Will Hu, the Chief Technology Officer. The executive team is focused on leveraging the new funds to advance their platform and expand their market reach.
Strategic Use of Funds
While specific plans for the use of the new capital were not disclosed, it is expected that the funding will be used to enhance product development, scale operations, and potentially expand into new markets. The backing from prominent investors underscores the confidence in Flagler Health's ability to innovate and grow within the healthcare technology sector.
Investor Insights
Bessemer Venture Partners, known for their strategic investments in technology-driven companies, leads this round, highlighting the potential they see in Flagler Health's approach to MSK care. The participation of other investors like SignalFire and Alumni Ventures further emphasizes the interest in innovative healthcare solutions.
Flagler Health's latest funding round marks a significant milestone as they continue to develop solutions that improve the coordination and efficiency of musculoskeletal care.